1997
DOI: 10.1111/j.1600-0625.1997.tb00172.x
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial cells and angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…[24][25][26] Proliferation and migration of ECs has been shown to be an essential criterion for angiogenesis. [27][28][29] We demonstrate active EC proliferation that turns the ischemic hemisphere into a highly plastic vascular system with multiple angiogenic sprouts. The continued angiogenic sprouting results in an increased vessel density in both perilesion and lesion region.…”
Section: Discussionmentioning
confidence: 87%
“…[24][25][26] Proliferation and migration of ECs has been shown to be an essential criterion for angiogenesis. [27][28][29] We demonstrate active EC proliferation that turns the ischemic hemisphere into a highly plastic vascular system with multiple angiogenic sprouts. The continued angiogenic sprouting results in an increased vessel density in both perilesion and lesion region.…”
Section: Discussionmentioning
confidence: 87%
“…PDGF and TGF-b are usually secreted in damaged tissues and stimulate proliferation of fibroblasts and smooth muscle cells resulting with enhanced synthesis of collagen and extracellular matrix which are necessary for wound healing [17]. Vessels formation is an important part of this process and both PDGF and TGF-b demonstrate chemotactic activity causing migration of pro-angiogenic inflammatory cells [18,19]. Psoriasis activity is an effect of imbalance between stimulation and inhibition of keratinocyte proliferation.…”
Section: Discussionmentioning
confidence: 99%
“…Tumor-specific targeting has been performed by using a drug conjugated to a tumor-specific molecule such as an adriamycin-conjugated poly (ethylene glycol) linker with enzymatically cleavable peptide sequences and monoclonal antibodies binding to specific tumor antigens such as rituximab, trastuzumab, gemtuzumabozogamicin, alemtuzumab, ibritumomab tiuxetan, and gefitinib (Abou-Jawde et al, 2003;Kohler & Milstein, 1975;Suzawa et al, 2002). Targeting through angiogenesis, a process vital to the continued development of a tumor mass has been performed by using the most prominent angiogenesis stimulatory molecules such as vascular endothelial growth factor, basic fibroblast growth factor, platelet-derived growth factor, transforming growth factors, and certain matrix metalloproteinases and some endogenous angiogenesis inhibitors such as the interferon family, angiopioetin, interleukin, thrombospondin-1 and -2, tissue inhibitor, angiostatin, and endostatin (Fox et al, 1993;Hobson & Denekamp, 1984;Ingber, 1990;Sepp et al, 1997).…”
Section: The Use Of Nanoparticles In Drug Deliverymentioning
confidence: 99%